Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€2.36

€2.36

-0.990%
-0.024
-0.990%
€7.00
 
26.03.24 / Tradegate WKN: A3DMH5 / Symbol: NERV / Name: Minerva Neurosciences / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Minerva Neurosciences Inc. Stock

Minerva Neurosciences Inc. shows a slight decrease today, losing -€0.024 (-0.990%) compared to yesterday.
Our community is currently low on Minerva Neurosciences Inc. with 1 Buy predictions and 5 Sell predictions.
On the other hand, the target price of 7 € is above the current price of 2.36 € for Minerva Neurosciences Inc., so the potential is actually 197.11%.
Our community identified positive and negative aspects for Minerva Neurosciences Inc. stock for the coming years. 5 users see the criterium "Worthwhile Investment for the next years" as a plus for the Minerva Neurosciences Inc. stock. On the other hand our users think that "Expected dividend yield" could be a problem in the future.

Minerva Neurosciences (NASDAQ: NERV) is a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients suffering from neuropsychiatric disorders. With a primary emphasis on central nervous system diseases such as schizophrenia, major depressive disorder, insomnia, and Parkinson's, Minerva Neurosciences is committed to addressing unmet medical needs and advancing the understanding of the underlying biology of these conditions. Utilizing a strong research and development platform, the company aims to create a diversified portfolio of novel therapies that have the potential to significantly improve patients' quality of life and help them lead more fulfilling lives.

Pros and Cons of Minerva Neurosciences Inc. in the next few years

Pros
?
B****
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
C******** o* t** e**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Minerva Neurosciences Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Minerva Neurosciences Inc. -0.990% -1.833% -9.663% 56.026% -59.623% -88.125% -
Salarius Pharmaceuticals Inc. 2.420% -18.824% -22.617% -76.389% -25.405% -98.665% -99.992%
Ardelyx Inc. -1.160% -6.371% -22.654% 73.980% 16.955% 25.791% -
Evolus Inc -0.770% 2.362% -2.985% 66.667% 39.037% 31.287% -

Comments

Minerva Neurosciences, Inc. (NASDAQ: NERV) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for NERV provided by MarketBeat
Show more

Minerva Neurosciences, Inc. (NASDAQ: NERV) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for NERV provided by MarketBeat
Show more

Minerva Neurosciences, Inc. (NASDAQ: NERV) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for NERV provided by MarketBeat
Show more